Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Yun Hee | - |
dc.contributor.author | Kang, Hatan | - |
dc.contributor.author | Lee, Won Kyu | - |
dc.contributor.author | Kim, Taehyun | - |
dc.contributor.author | Rhim, Hyewhon | - |
dc.contributor.author | Yu, Yeon Gyu | - |
dc.date.accessioned | 2024-01-21T01:00:43Z | - |
dc.date.available | 2024-01-21T01:00:43Z | - |
dc.date.created | 2022-01-10 | - |
dc.date.issued | 2007-06-30 | - |
dc.identifier.issn | 1226-3613 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/134308 | - |
dc.description.abstract | Serotonin receptor subtype 6 (5-HT6) is a neurotransmitter receptor, which is involved in various brain functions such as memory and mood. It mediates signaling via the interaction with a stimulatory G-protein. Especially, the third intracellular loop (iL3) of 5-HT6 and the alpha subunit of stimulatory G protein (G alpha(s)) are responsible for the signaling process of 5-HT6. Chemical compounds that could inhibit the interaction between the iL3 region of 5-HT6 and Get, were screened from a chemical library consisted of 5,600 synthetic compounds. One of the identified compounds bound to G alpha(s) and effectively blocked the interaction between G alpha(s) and the iL3 region of 5-HT6. The identified compound was further shown to reduce the serotonin-induced accumulation of cAMP in 293T cells transformed with 5-HT6 cDNA. It also lowered the Ca2+ efflux induced by serotonin in cells expressing 5-HT6 and chimeric G alpha(s5/q). These results indicate that the interaction between the iL3 of 5-HT6 and G alpha(s) can be exploited for screening of regulatory compounds against the signaling pathway of 5-HT6. | - |
dc.language | English | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.subject | PHARMACOLOGICAL CHARACTERIZATION | - |
dc.subject | 5-HYDROXYTRYPTAMINE RECEPTOR | - |
dc.subject | ADENYLATE-CYCLASE | - |
dc.subject | BINDING SITES | - |
dc.subject | RAT | - |
dc.subject | EXPRESSION | - |
dc.subject | CLONING | - |
dc.subject | CLASSIFICATION | - |
dc.subject | NOMENCLATURE | - |
dc.subject | RADIOLIGAND | - |
dc.title | An inhibitory compound against the interaction between Gas and the third intracellular loop region of serotonin receptor subtype 6 (5-HT6) disrupts the signaling pathway of 5-HT6 | - |
dc.type | Article | - |
dc.identifier.doi | 10.1038/emm.2007.37 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL AND MOLECULAR MEDICINE, v.39, no.3, pp.335 - 342 | - |
dc.citation.title | EXPERIMENTAL AND MOLECULAR MEDICINE | - |
dc.citation.volume | 39 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 335 | - |
dc.citation.endPage | 342 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.kciid | ART001059165 | - |
dc.identifier.wosid | 000247798800010 | - |
dc.identifier.scopusid | 2-s2.0-34447130218 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | PHARMACOLOGICAL CHARACTERIZATION | - |
dc.subject.keywordPlus | 5-HYDROXYTRYPTAMINE RECEPTOR | - |
dc.subject.keywordPlus | ADENYLATE-CYCLASE | - |
dc.subject.keywordPlus | BINDING SITES | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CLONING | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | NOMENCLATURE | - |
dc.subject.keywordPlus | RADIOLIGAND | - |
dc.subject.keywordAuthor | gTP-binding protein asubunits | - |
dc.subject.keywordAuthor | Gs | - |
dc.subject.keywordAuthor | serotonin | - |
dc.subject.keywordAuthor | serotonin 6 receptor | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.